TCWM
AMPH icon

Total Clarity Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Total Clarity Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-207
Closed -$7K – 254
2022
Q2 		$7K Buy
+207
New +$7.39K ﹤0.01% 739
2022
Q1 		– Sell
-325
Closed -$8K – 245
2021
Q4 		$8K Buy
+325
New +$6.65K ﹤0.01% 727

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Total Clarity Wealth Management's AMPH Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 207 shares — an estimated $7K sold.

Total Clarity Wealth Management first reported a position in AMPH in Q4 2021 and held it in 2 quarters. The position peaked at $8K in Q4 2021. 205 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 207 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $7K.
  • Total Clarity Wealth Management first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Total Clarity Wealth Management's Amphastar Pharmaceuticals position peaked at $8K in Q4 2021.
  • 205 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.